FDA issued a Warning Letter to Andapharm, LLC on 2/28/2019 as a result of this inspection.
483 Andapharm Jul 2018

483 Andapharm Jul 2018

Tajah Blackburn FDA, Gideon Esuzor FDA$119.00 - Available Now

FDA investigators audited the Andapharm - Fort Lauderdale, FL, United States facility and issued inspectional observations (via FDA 483) on 18 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jul 2018
  • Location: Fort Lauderdale, United States
  • FEI: 3005000348
Add To Cart